Abstract
RationaleAcetazolamide and atomoxetine-plus-oxybutynin (‘AtoOxy’) can improve obstructive sleep apnoea (OSA) by stabilising ventilatory control and improving dilator muscle responsiveness respectively. Given the different pathophysiological mechanisms targeted by each intervention, we...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have